Flow Cytometry Market Research Report – Forecast to 2023

Flow Cytometry Market Research Report – Forecast to 2023

ID: MRFR/HC/4972-HCRR | October, 2018 | Region: Global | 100 pages | Half-Cooked Research Reports

Global Flow Cytometry Market: Information by Product & service (Reagents and Consumables), Technology (Cell-Based Flow Cytometry), Application (Research Applications and Immunology), End-User (Research Institutes, Commercial) –Global Forecast Till 2023


Market Scenario


The global flow cytometry market is expected to grow during the forecast period (2018–2023) at a CAGR ~11.5%.


Flow cytometry is used to determine the physical and chemical characteristics of a cell or a particle. Flow cytometry of a cell can determine the cell size, cell count, cell cycle and other characteristics of the cell. It helps scientists and researchers to extract specific information about the cell or particle. The increasing use of flow cytometry in diagnosis, increasing applications of flow cytometry in healthcare research and growing adoption of new technology are responsible for the growth of the market. Moreover, the rising prevalence of HIV/AIDS and cancer cases are contributing to the growth of the market. According to the UNAIDS, in the year 2015 more than 36.7 million people worldwide were affected by HIV/AIDS and out of which 1.8 million were children below 15 yrs.


The high costs of flow cytometry instruments and reagents, lack of awareness about applications of flow cytometry and scarcity of technicians may hamper the growth of the market during the assessment period.


Segmentation


The global flow cytometry market has been segmented on the basis of products & services, technology, application, and end-user.


On the basis of products & services, the market has been classified as reagents and consumables, flow cytometry instruments, services, software, and accessories. The flow cytometry instruments segment has been further divided into cell analyzers and cell sorters.


The market by technology has been divided into cell-based flow cytometry and bead-based flow cytometry.


 The application segment has been divided into research applications, clinical applications, and industrial applications. The research applications segment has been segmented into pharmaceutical and biotechnology and immunology. The pharmaceutical and biotechnology sub-segment has been divided into drug discovery, stem cell research, and in vitro toxicity testing. Furthermore, the immunology segment has been sub-segmented into cell sorting, apoptosis, cell cycle analysis, cell viability, cell counting, and other research applications. The clinical applications segment includes cancer, hematology, immunodeficiency diseases, organ transplantation, and other clinical applications.


The market, by end-user, has been segmented into commercial, research institutes, hospitals and clinics, and academic institutes.


 The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The flow cytometry market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.


The European flow cytometry market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 


The flow cytometry market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The flow cytometry market in the Middle East & Africa has been segmented into the Middle East and Africa.


Regional Market Summary


Global Flow Cytometry Market Share, by Region, 2017 (%)


Flow Cytometry Market Share


Source: MRFR Analysis


The Americas are likely to dominate the global flow cytometry market owing to the presence of a well-established healthcare system, adoption of highly advanced technology and increase in the number of patients suffering from autoimmune diseases in the region and with that the increase in the use of flow cytometry for diagnostics purpose.  According to the American Autoimmune Related Diseases Association, more than 50 million Americans are suffering from autoimmune diseases and autoimmune disease is one of the top ten causes of death in women and children.


The European market is expected to be the second-largest flow cytometry market. The market growth in this region can be attributed to government funding and support to the research and development activities, raising awareness about healthcare diagnostics and increasing cases of cancer patients in the region. Moreover, increasing research and development activities in the pharmaceutical industry is contributing to the growth of the market in this region. For instance, according to the European Federation of Pharmaceutical Industries and Associations, in the year 2015, the European pharmaceutical sector has invested more than USD 33,557 million in research and development activities.


Asia-Pacific is expected to be the fastest-growing flow cytometry market during the forecast period owing to the increasing prevalence of autoimmune diseases, increasing awareness about healthcare and rising investments and collaborative activities in healthcare and expansions by market players in the region. For instance, in June 2017, Beckman Coulter, Inc. entered into extensive distribution agreement with Grifols S.A to expand its diagnostics portfolio.


The market in the Middle East & Africa is expected to account for the smallest share of the global flow cytometry market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.


Key Players


Some of the key players in the flow cytometry are Beckman Coulter, Inc., Becton, Dickinson and Company., Danaher., Thermo Fisher Scientific, Merck KGaA, Bio-Rad Laboratories, Inc., Luminex Corporation., Miltenyi Biotec, Sysmex Partec GmbH, Agilent Technologies, Inc., Sony Corporation, Biomérieux S.A., and Enzo Biochem Inc.


Global Flow Cytometry Market, by Products & Services



  • Reagents and Consumables

  • Flow Cytometry Instruments


    • Cell Analyzers

    • Cell Sorters


  • Services

  • Software

  • Accessories


Global Flow Cytometry Market, by Technology



  • Cell-Based Flow Cytometry

  • Bead-Based Flow Cytometry


Global Flow Cytometry Market, by Application



  • Research Applications

    • Drug Discovery

    • Stem Cell Research

    •  In Vitro Toxicity Testing



    • Cell Sorting

    • Apoptosis

    • Cell Cycle Analysis

    • Cell Viability

    • Cell Counting

    • Other Research Applications




    • Pharmaceutical and Biotechnology

    • Immunology


  • Clinical Applications


    • Cancer

    • Hematology

    • Immunodeficiency Diseases

    • Organ Transplantation

    • Other Clinical Applications


  • Industrial Application


Global Flow Cytometry Market, by End-User



  • Commercial

  • Research Institutes

  • Hospitals and Clinics

  • Academic Institutes


Global Flow Cytometry Market, by Region


Americas


  • North America

  • US

  • Canada

  • South America


Europe


  • Western Europe

  • Germany

  • France

  • Italy

  • Spain

  • UK

  • Rest of Western Europe

  • Eastern Europe


Asia-Pacific


  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Rest of Asia-Pacific


Middle East & Africa


  • Middle East

  • Africa


Intended Audience



  • Flow cytometry equipment and reagent manufacturers

  • Flow cytometry equipment distributors and suppliers

  • Healthcare providers

  • Medical device manufacturers

  • Research institutes and academic centers

  • Contract research organizations (CROs)

  • Government associations

  • Market research and consulting

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary Research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Global Flow Cytometry Market, by Products & Services

6.1 Introduction

6.2 Products & Services

6.2.1 Reagents and Consumables

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.2.2 Flow Cytometry Instruments

6.2.2.1 Cell Analyzers

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.2.2.2 Cell Sorters

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.2.3 Services

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023



6.2.4 Software

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

6.2.5 Accessories

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023



Chapter 7. Global Flow Cytometry Market, by Technology

7.1 Introduction

7.2 Cell-Based Flow Cytometry

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

7.3 Bead-Based Flow Cytometry

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023



Chapter 8. Global Flow Cytometry Market, by Application

8.1 Introduction

8.2 Research Applications

8.2.1 Pharmaceutical and Biotechnology

8.2.1.1 Drug Discovery

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.2.1.2 Stem Cell Research

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.2.1.3 In Vitro Toxicity Testing

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.2.2 Immunology

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.2.2.1 Cell Sorting

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.2.2.2 Apoptosis

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.2.2.3 Cell Cycle Analysis

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.2.2.4 Cell Viability

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.2.2.5 Cell Counting

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.2.2.6 Other Research Applications

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023



8.3 Clinical Applications

8.3.1 Cancer

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.3.2 Hematology

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.3.3 Immunodeficiency Diseases

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.3.4 Organ Transplantation

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.3.5 Other Clinical Applications

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

8.4 Industrial Application

Market Estimates & Forecast, by Country, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

Chapter 9. Global Flow Cytometry Market, by End-User

9.1 Introduction

9.2 Commercial

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

9.3 Research Institutes

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

9.4 Hospitals and Clinics

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023

9.5 Academic Institutes

Market Estimates & Forecast, by Region, 2018–2023

Market Estimates & Forecast, by Country, 2018–2023



Chapter 10. Global Flow Cytometry Market, by Region

10.1 Introduction

10.2 Americas

10.2.1 North America

10.2.1.1 US

10.2.1.2 Canada

10.2.2 South America

10.3 Europe

10.3.1 Western Europe

10.3.1.1 Germany

10.3.1.2 France

10.3.1.3 Italy

10.3.1.4 Spain

10.3.1.5 UK

10.3.1.6 Rest of Western Europe

10.3.2 Eastern Europe

10.4 Asia-Pacific

10.4.1 Japan

10.4.2 China

10.4.3 India

10.4.4 Australia

10.4.5 South Korea

10.4.6 Rest of Asia-Pacific

10.5 Middle East & Africa

10.5.1 Middle East

10.5.2 Africa

Chapter 11. Company Landscape

11.1 Introduction

11.2 Market Share Analysis

11.3 Key Development & Strategies

Chapter 12. Company Profiles

12.1 Beckman Coulter, Inc.

12.1.1 Company Overview

12.1.2 Product Overview

12.1.3 Financials Overview

12.1.4 Key Developments

12.1.5 SWOT Analysis

12.2 Becton, Dickinson and Company

12.2.1 Company Overview

12.2.2 Product Overview

12.2.3 Financial Overview

12.2.4 Key Developments

12.2.5 SWOT Analysis

12.3 Danaher

12.3.1 Company Overview

12.3.2 Product Overview

12.3.3 Financial Overview

12.3.4 Key Development

12.3.5 SWOT Analysis

12.4 Thermo Fisher Scientific

12.4.1 Company Overview

12.4.2 Technology/Business Segment Overview

12.4.3 Financial Overview

12.4.4 Key Development

12.4.5 SWOT Analysis

12.5 Merck KGaA

12.5.1 Company Overview

12.5.2 Product Overview

12.5.3 Financial overview

12.5.4 Key Developments

12.5.5 SWOT Analysis

12.6 Bio-Rad Laboratories, Inc.

12.6.1 Company Overview

12.6.2 Product Overview

12.6.3 Financial Overview

12.6.4 Key Developments

12.6.5 SWOT Analysis

12.7 Luminex Corporation.

12.7.1 Overview

12.7.2 Product Overview

12.7.3 Financial Overview

12.7.4 Key Developments

12.7.5 SWOT Analysis

12.8 Miltenyi Biotec

12.8.1 Overview

12.8.2 Product/ Technology Overview

12.8.3 Financials

12.8.4 Key Developments

12.8.5 SWOT Analysis

12.9 Sysmex Partec GmbH

12.9.1 Overview

12.9.2 Product Overview

12.9.3 Financials

12.9.4 Key Developments

12.9.5 SWOT Analysis

12.10 Agilent Technologies, Inc.

12.10.1 Overview

12.10.2 Product Overview

12.10.3 Financials

12.10.4 Key Developments

12.10.5 SWOT Analysis

12.11 Sony Corporation

12.11.1 Overview

12.11.2 Product Overview

12.11.3 Financials

12.11.4 Key Developments

12.11.5 SWOT Analysis

12.12 Biomérieux S.A.

12.12.1 Overview

12.12.2 Product Overview

12.12.3 Financials

12.12.4 Key Developments

12.12.5 SWOT Analysis

12.13 Enzo Biochem, Inc.

12.13.1 Overview

12.13.2 Product Overview

12.13.3 Financials

12.13.4 Key Developments

12.13.5 SWOT Analysis

Chapter 13 MRFR Conclusion

13.1 Key Findings

13.1.1 From CEO’s Viewpoint

13.1.2 Unmet Needs of the Market

13.2 Key Companies to Watch

13.3 Predictions for the Flow Cytometry Industry

Chapter 14. Appendix

LIST OF TABLES

Table 1 Global Flow Cytometry Market Synopsis, 2018–2023

Table 2 Global Flow Cytometry Market Estimates and Forecast, 2018–2023 (USD Million)

Table 3 Global Flow Cytometry Market, by Region, 2018–2023 (USD Million)

Table 4 Global Flow Cytometry Market, by Products & Services, 2018–2023 (USD Million)

Table 5 Global Flow Cytometry Market, by Technology, 2018–2023 (USD Million)

Table 6 Global Flow Cytometry Market, by Application, 2018–2023 (USD Million)

Table 7 Global Flow Cytometry Market, by End-User, 2018–2023 (USD Million)

Table 8 North America: Flow Cytometry Market, by Products & Services, 2018–2023 (USD

Million)

Table 9 North America: Flow Cytometry Market, by Technology, 2018–2023 (USD

Million)

Table 10 North America: Flow Cytometry Market, by Application, 2018–2023 (USD

Million)

Table 11 North America: Flow Cytometry Market, by End-User, 2018–2023 (USD

Million)

Table 12 US: Flow Cytometry Market, by Products & Services, 2018–2023 (USD Million)

Table 13 US: Flow Cytometry Market, by Technology, 2018–2023 (USD Million)

Table 14 US: Flow Cytometry Market, by Application, 2018–2023 (USD Million)

Table 15 US: Flow Cytometry Market, by End-User, 2018–2023 (USD Million)

Table 16 Canada: Flow Cytometry Market, by Products & Services, 2018–2023 (USD Million)

Table 17 Canada: Flow Cytometry Market, by Technology, 2018–2023 (USD Million)

Table 18 Canada: Flow Cytometry Market, by Application, 2018–2023 (USD

Million)

Table 19 Canada: Flow Cytometry Market, by End-User, 2018–2023 (USD

Million)

Table 20 South America: Flow Cytometry Market, by Product, 2018–2023 (USD

Million)

Table 21 South America: Flow Cytometry Market, by Technology, 2018–2023 (USD

Million)

Table 22 South America: Flow Cytometry Market, by Application, 2018–2023 (USD

Million)

Table 23 South America: Flow Cytometry Market, by End-User, 2018–2023 (USD

Million)

Table 24 Europe: Flow Cytometry Market, by Products & Services, 2018–2023 (USD Million)

Table 25 Europe: Flow Cytometry Market, by Technology, 2018–2023 (USD Million)

Table 26 Europe: Flow Cytometry Market, by Application, 2018–2023 (USD Million)

Table 27 Europe: Flow Cytometry Market, by End-User, 2018–2023 (USD Million)

Table 28 Western Europe: Flow Cytometry Market, by Products & Services, 2018–2023 (USD

Million)

Table 29 Western Europe: Flow Cytometry Market, by Technology, 2018–2023 (USD

Million)

Table 30 Western Europe: Flow Cytometry Market, by Application, 2018–2023

(USD Million)

Table 31 Western Europe: Flow Cytometry Market, by End-User, 2018–2023

(USD Million)

Table 32 Eastern Europe: Flow Cytometry Market, by Products & Services, 2018–2023 (USD

Million)

Table 33 Eastern Europe: Flow Cytometry Market, by Technology, 2018–2023 (USD

Million)

Table 34 Eastern Europe: Flow Cytometry Market, by Application, 2018–2023

(USD Million)

Table 35 Eastern Europe: Flow Cytometry Market, by End-User, 2018–2023

(USD Million)

Table 36 Asia-Pacific: Flow Cytometry Market, by Products & Services, 2018–2023 (USD

Million)

Table 37 Asia-Pacific: Flow Cytometry Market, by Technology, 2018–2023 (USD

Million)

Table 38 Asia-Pacific: Flow Cytometry Market, by Application, 2018–2023 (USD

Million)

Table 39 Asia-Pacific: Flow Cytometry Market, by End-User, 2018–2023 (USD

Million)

Table 40 Middle East & Africa: Flow Cytometry Market, by Products & Services, 2018–2023

(USD Million)

Table 41 Middle East & Africa: Flow Cytometry Market, by Technology, 2018–2023

(USD Million)

Table 42 Middle East & Africa: Flow Cytometry Market, by Application, 2018–2023

(USD Million)

Table 43 Middle East & Africa: Flow Cytometry Market, by End-User, 2018–2023

(USD Million)



LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation for Global Flow Cytometry Market

Figure 3 Segmentation Market Dynamics for Global Flow Cytometry Market

Figure 4 Global Flow Cytometry Market Share, by Products & Services, 2017

Figure 5 Global Flow Cytometry Market Share, by Technology, 2017

Figure 6 Global Flow Cytometry Market Share, by Application, 2017

Figure 7 Global Flow Cytometry Market Share, by End-User, 2017

Figure 8 Global Flow Cytometry Market Share, by Region, 2017

Figure 9 North America: Flow Cytometry Market Share, by Country, 2017

Figure 10 Europe: Flow Cytometry Market Share, by Country, 2017

Figure 11 Asia-Pacific: Flow Cytometry Market Share, by Country, 2017

Figure 12 Middle East & Africa: Flow Cytometry Market Share, by Country, 2017

Figure 13 Global Flow Cytometry Market: Company Share Analysis, 2017 (%)

Figure 14 Beckman Coulter, Inc.: Key Financials

Figure 15 Beckman Coulter, Inc.: Segmental Revenue

Figure 16 Beckman Coulter, Inc.: Geographical Revenue

Figure 17 Becton, Dickinson and Company.: Key Financials

Figure 18 Becton, Dickinson and Company.: Segmental Revenue

Figure 19 Becton, Dickinson and Company.: Geographical Revenue

Figure 20 Danaher: Key Financials

Figure 21 Danaher: Segmental Revenue

Figure 22 Danaher: Geographical Revenue

Figure 23 Thermo Fisher Scientific: Key Financials

Figure 24 Thermo Fisher Scientific: Segmental Revenue

Figure 25 Thermo Fisher Scientific: Geographical Revenue

Figure 26 Merck KGaA: Key Financials

Figure 27 Merck KGaA: Segmental Revenue

Figure 28 Merck KGaA. Geographical Revenue

Figure 29 Bio-Rad Laboratories, Inc.: Key Financials

Figure 30 Bio-Rad Laboratories, Inc.: Segmental Revenue

Figure 31 Bio-Rad Laboratories, Inc.: Geographical Revenue

Figure 32 Luminex Corporation.: Key Financials

Figure 33 Luminex Corporation.: Segmental Revenue

Figure 34 Luminex Corporation.: Geographical Revenue

Figure 35 Miltenyi Biotec: Key Financials

Figure 36 Miltenyi Biotec: Segmental Revenue

Figure 37 Miltenyi Biotec: Geographical Revenue

Figure 38 Sysmex Partec GmbH: Key Financials

Figure 39 Sysmex Partec GmbH: Segmental Revenue

Figure 40 Sysmex Partec GmbH: Geographical Revenue

Figure 41 Agilent Technologies, Inc.: Key Financials

Figure 42 Agilent Technologies, Inc.: Segmental Revenue

Figure 43 Agilent Technologies, Inc.: Geographical Revenue

Figure 44 Sony Corporation: Key Financials

Figure 45 Sony Corporation: Segmental Revenue

Figure 46 Sony Corporation: Geographical Revenue

Figure 47 Biomérieux S.A.: Key Financials

Figure 48 Biomérieux S.A.: Segmental Revenue

Figure 49 Biomérieux S.A.: Geographical Revenue

Figure 50 Enzo Biochem, Inc.: Key Financials

Figure 51 Enzo Biochem, Inc.: Segmental Revenue

Figure 52 Enzo Biochem, Inc.: Geographical Revenue